SCHEMBL929036

SCHEMBL929036

CC(C)(C)c1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)NCc2ccc(OCCC(=O)O)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
LMNA P02545 3/20 0.44
POLB P06746 1/20 0.44
MMP8 P22894 3/20 0.42
MMP3 P08254 2/20 0.42
GPR35 Q9HC97 1/20 0.42
GLA P06280 1/20 0.42
PKM P14618 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.41
EPHX2 P34913 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MITF O75030 1/20 0.40
GAA P10253 1/20 0.40
FKBP1A P62942 1/20 0.40
HDAC8 Q9BY41 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926858 0.91 PKM (0.42) ALDH1A1NPSR1LMNAMMP8MMP3
SCHEMBL926069 0.89 NR1H4 (0.48) ALDH1A1LMNAPOLBGLAPKM
SCHEMBL926836 0.88 FKBP1A (0.48) ALDH1A1LMNAPOLBGLAPKM
SCHEMBL925329 0.87 EPHX2 (0.47) ALDH1A1LMNAPOLBMMP8MMP3
SCHEMBL926278 0.87 MMP8 (0.44) ALDH1A1NPSR1LMNAPOLBMMP8
SCHEMBL926562 0.86 NPC1 (0.50) ALDH1A1NPSR1LMNAPOLBMMP8
SCHEMBL926246 0.86 EPHX2 (0.48) ALDH1A1LMNAPOLBGLAPKM
SCHEMBL4842189 0.85 RORC (0.43)
SCHEMBL926437 0.85 LMNA (0.47) ALDH1A1LMNAPOLBGLAPKM
SCHEMBL927263 0.85 LMNA (0.49) ALDH1A1LMNAPOLBGLAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD ALDH1A1 2845/4885NPSR1 297/4885LMNA 1809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.